Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 44, Issue 3, Pages 587-597Publisher
SPRINGER
DOI: 10.1007/s40618-020-01356-9
Keywords
Calcitonin; Calcium test; Cut-off; Medullary thyroid cancer; Bradycardia
Categories
Funding
- UniversitA degli Studi di Milano within the CRUI-CARE Agreement
Ask authors/readers for more resources
This study provides refined cut-offs for basal and calcium stimulated calcitonin in patients with nodular goiter, demonstrating the high accuracy of sensitive basal in diagnosis, but the need for combination with calcitonin data to identify all medullary thyroid cancer cases. The reliability and safety of the calcium test strongly support its routine use in nodular thyroid disease.
Purpose Reliable cut-offs for basal (bCT) and calcium stimulated calcitonin (casCT) are needed for an early and accurate diagnosis of medullary thyroid cancer (MTC). Patients and methods Fifty-four new patients with nodular goiter were enrolled and analysed together with those previously published by our group for a total of 135 cases. bCT and casCT were measured by a highly sensitive method and the results compared with histological findings. In a subgroup of patients, cardiac rhythm was recorded before and during the calcium test. Results In both females (F) and males (M), there was a significant correlation between tumor size and bCT levels (P < 0.001). The receiver operating characteristic plot analyses showed that, for bCT, the new cut-off points able to separate non-MTC from MTC patients were > 30 (F) and > 34 pg/mL (M), whereas the best casCT thresholds were > 79 (F) and > 466 pg/mL (M). bCT was shown to harbour a high accuracy, though some cases were diagnosed only upon stimulation test. Importantly, combining bCT, below or above the cut-offs, with casCT above the cut-offs, all the MTC cases were correctly identified. A reversible sinus bradycardia was observed in 9% of cases during the test. Conclusions Refined cut-offs for bCT and casCT in patients with nodular goiter are reported. Sensitive bCT was shown to have a high accuracy, but the combination with casCT data was needed to identify all MTC cases. The reliability and safety of calcium test strongly favour the routine use of CT determination in nodular thyroid disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available